Chancroid is a bacterial sexually transmitted infection caused by the fastidious Gram-negative streptobacillus Haemophilus ducreyi. The disease is characterized by painful sores on the genitalia and represents a distinct clinical entity from syphilitic chancres, often referred to colloquially as 'soft chancre' to contrast with the 'hard chancre' of primary syphilis. The pathogen is highly infectious and produces localized disease without systemic manifestations.
Disease Profile
BacterialChancroid
软下疳
Chancroid is a bacterial sexually transmitted infection caused by Haemophilus ducreyi, characterized by painful genital ulcers and potential complications involving inguinal lymphadenopathy. The disease occurs primarily in developing countries among populations with limited access to healthcare, though sporadic cases have been documented in industrialized nations. While not nationally notifiable in most jurisdictions, chancroid remains clinically significant due to its role in genital ulcer disease and its epidemiological association with high-risk sexual networks.
Chancroid presents with painful genital ulcers that are typically confined to the genital region without systemic involvement. Men frequently develop a single ulcer, while women more commonly present with four or more ulcers, often with fewer associated symptoms. Approximately one-third of infected individuals develop enlargement of the inguinal lymph nodes, and half of those with lymphadenopathy progress to rupture through the skin, producing draining abscesses known as buboes. The ulceration progresses through characteristic stages from erythematous papule to pustule over 4-7 days, followed by central necrosis and ulcer formation.
Chancroid is found primarily in developing countries and remains most prevalent among low socioeconomic groups with associated commercial sex work. In the United States, the infection has been isolated in up to 10% of genital ulcer cases diagnosed at STI clinics in Memphis and Chicago, though overall infection levels in Western countries are very low, typically around one case per two million population in Canada, France, Australia, and the UK. The disease is considered a marker of sexual network characteristics and healthcare access patterns.
Chancroid spreads from one individual to another solely through sexual contact, with the pathogen entering skin through microabrasions incurred during intercourse. The incubation period ranges from 10 to 14 days before clinical progression. There have been rare reports of accidental infection through the hand, though such transmission is exceptional and not a significant epidemiological concern.
Populations at elevated risk include individuals in developing countries, particularly those in low socioeconomic groups with limited healthcare access. Commercial sex workers represent a key epidemiological reservoir in endemic settings. The disease is strongly associated with sexual network characteristics rather than inherent biological susceptibility, meaning risk is primarily determined by exposure opportunity within high-prevalence populations.
Public health prevention measures for chancroid align with general sexually transmitted infection control strategies, emphasizing barrier protection and partner notification. Source-backed detail on specific prevention protocols is not yet available in the provided material. The disease's association with high-risk sexual networks in resource-limited settings suggests that comprehensive STI prevention programs addressing multiple concurrent infections may be most effective.
Chancroid is not a nationally notifiable disease in most jurisdictions, limiting routine surveillance data availability. Laboratory confirmation remains challenging due to the fastidious nature of H. ducreyi, with culture sensitivity below 80% and no FDA-cleared PCR assays available in the United States. Diagnosis is frequently presumptive based on clinical presentation of multiple painful genital ulcers, particularly in settings where alternative diagnoses have been excluded. The disease's low prevalence in Western settings means that clinicians may have limited experience with recognition and management.
Figure 1 | Full historical trajectories across all reporting countries.
Figure 2 | Year-over-year monthly comparison for seasonality and structural shifts.
Dataset Archive
Supplementary Data | Multi-country disease dataset
Machine-readable multi-country disease dataset (JSON/CSV) with source metadata.
Source Register
Official sources and update cadences used to construct the downloadable dataset.
Australia
Australian national notifiable diseases surveillance dashboard.
Official sourceUnited States
CDC National Notifiable Diseases Surveillance System provisional data.
Official source